Targeted delivery of nanoparticles to the heart endothelium with large pay-load potential, applicable to drug/gene delivery.
Ligand-targeted liposomes are increasingly being recognized as an effective strategy to deliver drugs to specific organs; however, few studies have quantified endothelial binding of targeted liposomes. Researchers at the University of California, Davis have discovered that embedding high concentrations of short, linear, arginine-terminated peptides into nanoparticles allows for concentrated binding of the particles selectively to heart endothelium and the vascular endothelium in the heart.
Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 8,506,928 | 08/13/2013 | 2008-157 |
cardiovascular system, cardiac, cardiac endothelium, heart muscle, drug delivery, targeted, nanoparticles, nanodroplets, imaging